FIELD: medicine.
SUBSTANCE: invention relates to ophthalmology, namely to a method for prediction of intraoperative haemorrhagic complications in severe form of proliferative diabetic retinopathy. For this purpose, blood serum is examined for endothelin content and if its concentration is 3 and more fmole/ml intraoperative haemorrhagic complications are predicted.
EFFECT: invention enables developing a differentiated preoperative approach to preparing a patient for surgical intervention aimed at reducing the risk of intraoperative haemorrhagic complications in the patients at risk.
1 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING INTRAOPERATIVE HEMORRHAGIC COMPLICATIONS IN HEAVY FORM OF DIABETIC RETHYNOPATHY | 2016 |
|
RU2626681C1 |
| METHOD OF EARLY DIAGNOSIS OF FAMILIAL EXUDATIVE RETINOPATHY IN CHILDREN | 2022 |
|
RU2796894C1 |
| METHOD FOR EARLY DIAGNOSIS AND PREDICTION OF MACULAR EDEMA IN DIABETIC RETINOPATHY | 2020 |
|
RU2741693C1 |
| METHOD FOR PREVENTION OF INTRAOPERATIVE HAEMORRHAGIC COMPLICATIONS IN SURGERY OF PROLIFERATIVE DIABETIC RETINOPATHY | 2018 |
|
RU2703707C2 |
| METHOD OF SURGICAL TREATMENT OF PATIENTS WITH PROLIFERATIVE VITRECTONOMY WITH SYNECHIAE REMOVAL AGAINST THE BACKGROUND OF DIABETES MELLITUS | 2017 |
|
RU2675463C1 |
| METHOD OF CONSERVATIVE TREATMENT OF RECURRENT HAEMOPHTHALMIA IN DIABETIC RETINOPATHY | 2012 |
|
RU2485944C1 |
| METHOD OF DIAGNOSING COMPLICATIONS IN CASE OF PROLIFERATIVE DIABETIC RETONOPATHY IN PATIENTS WITH NON-TRANSPARENT OPTIC EYE MEDIA | 2009 |
|
RU2407428C1 |
| METHOD FOR PREVENTING HEMORRHAGIC COMPLICATIONS OF VITREORETINAL SURGERY | 2021 |
|
RU2773104C1 |
| METHOD FOR REMOVAL OF FIBROUS-ALTERED POSTERIOR HYALOID FACE (PHF) IN PROLIFERATIVE RETINOPATHY | 2021 |
|
RU2759234C1 |
| METHOD FOR TREATING THE CASES OF DIABETIC RETINOPATHY | 2002 |
|
RU2212869C1 |
